Atea Pharmaceuticals
AVIR
AVIR
106 hedge funds and large institutions have $190M invested in Atea Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
+3
Holders Change %
+2.91%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
37
Reduced
26
Closed
10
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$28K
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
$5.08M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.05M |
| 3 |
Two Sigma Advisers
New York
|
$2.52M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$17.6M |
| 5 |
Two Sigma Investments
New York
|
$1.32M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$12.4K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$20.6M |
| 3 |
BlackRock
New York
|
$31.2M |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
$1.6M |
| 5 |
D.E. Shaw & Co
New York
|
$705K |
